ABSK-021
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ABSK-021, covering 2026-03-19 to 2026-03-19. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-021 in Patients With Advanced Solid Tumor [Phase 1]